TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 524.46B
Enterprise Value 353.52B
Trailing P/E N/A
Forward P/E 18.55
PEG Ratio (5 yr expected) 1-1.04
Price/Sales (ttm)1.12
Price/Book (mrq)1.64
Enterprise Value/Revenue 32.45
Enterprise Value/EBITDA 69.01

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin -72.43%
Operating Margin (ttm)17.44%

Management Effectiveness

Return on Assets (ttm)2.96%
Return on Equity (ttm)-57.14%

Income Statement

Revenue (ttm)21.8B
Revenue Per Share (ttm)21.45
Quarterly Revenue Growth (yoy)-10.40%
Gross Profit (ttm)10.82B
EBITDA 5.94B
Net Income Avi to Common (ttm)-16.05B
Diluted EPS (ttm)-15.79
Quarterly Earnings Growth (yoy)73.60%

Balance Sheet

Total Cash (mrq)1.42B
Total Cash Per Share (mrq)1.39
Total Debt (mrq)30.75B
Total Debt/Equity (mrq)152.98
Current Ratio (mrq)1.00
Book Value Per Share (mrq)14.66

Cash Flow Statement

Operating Cash Flow (ttm)4.87B
Levered Free Cash Flow (ttm)3.4B

Trading Information

Stock Price History

Beta 1.10
52-Week Change 3-22.69%
S&P500 52-Week Change 313.05%
52 Week High 333.82
52 Week Low 310.85
50-Day Moving Average 321.06
200-Day Moving Average 319.28

Share Statistics

Avg Vol (3 month) 311.57M
Avg Vol (10 day) 311.62M
Shares Outstanding 51.02B
Float 932.77M
% Held by Insiders 14.06%
% Held by Institutions 167.34%
Shares Short 353.6M
Short Ratio 33.42
Short % of Float 3N/A
Shares Short (prior month) 353.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.17
Trailing Annual Dividend Yield 30.70%
5 Year Average Dividend Yield 43.22
Payout Ratio 4N/A
Dividend Date 3Dec 12, 2017
Ex-Dividend Date 4Nov 27, 2017
Last Split Factor (new per old) 22/1
Last Split Date 3Jul 1, 2004